Can exercise at home help 9/11 responders with prostate cancer?
NCT ID NCT07440641
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study will test whether a live, supervised exercise program done at home via video is feasible and helpful for World Trade Center responders who have had prostate cancer. Forty participants will be randomly assigned to either the 16-week exercise program or a waitlist. The study aims to see if the program improves physical function, activity levels, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remote supervised exercise program
- What this could lead to
- If successful, this could provide an accessible way to improve physical function and quality of life for WTC responders with prostate cancer.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to everyone. The program may not be feasible or acceptable for all participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Vermont
Burlington, Vermont, 05401, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?